These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 1849710)

  • 1. Effects of ciprofloxacin on plasmid DNA supercoiling of Escherichia coli topoisomerase I and gyrase mutants.
    Aleixandre V; Herrera G; Urios A; Blanco M
    Antimicrob Agents Chemother; 1991 Jan; 35(1):20-3. PubMed ID: 1849710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling.
    Aleixandre V; Urios A; Herrera G; Blanco M
    Mol Gen Genet; 1989 Oct; 219(1-2):306-12. PubMed ID: 2559316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.
    Bagel S; Hüllen V; Wiedemann B; Heisig P
    Antimicrob Agents Chemother; 1999 Apr; 43(4):868-75. PubMed ID: 10103193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
    Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
    J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants.
    Pruss GJ; Franco RJ; Chevalier SG; Manes SH; Drlica K
    J Bacteriol; 1986 Oct; 168(1):276-82. PubMed ID: 3019999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escherichia coli DNA topoisomerase I mutants: increased supercoiling is corrected by mutations near gyrase genes.
    Pruss GJ; Manes SH; Drlica K
    Cell; 1982 Nov; 31(1):35-42. PubMed ID: 6297751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discoordinate gene expression of gyrA and gyrB in response to DNA gyrase inhibition in Escherichia coli.
    Neumann S; Quiñones A
    J Basic Microbiol; 1997; 37(1):53-69. PubMed ID: 9090126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87).
    Barnard FM; Maxwell A
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1994-2000. PubMed ID: 11408214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of topoisomerases in maintaining steady-state DNA supercoiling in Escherichia coli.
    Zechiedrich EL; Khodursky AB; Bachellier S; Schneider R; Chen D; Lilley DM; Cozzarelli NR
    J Biol Chem; 2000 Mar; 275(11):8103-13. PubMed ID: 10713132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of DNA topoisomerases involved in immediate and transient DNA relaxation induced by heat shock in Escherichia coli.
    Ogata Y; Mizushima T; Kataoka K; Miki T; Sekimizu K
    Mol Gen Genet; 1994 Sep; 244(5):451-5. PubMed ID: 8078472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
    Gootz TD; Zaniewski RP; Haskell SL; Kaczmarek FS; Maurice AE
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase mutants and physiological conditions control supercoiling and Z-DNA formation in vivo.
    Jaworski A; Higgins NP; Wells RD; Zacharias W
    J Biol Chem; 1991 Feb; 266(4):2576-81. PubMed ID: 1846630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression in Escherichia coli of Y5 mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
    Brino L; Mousli M; Oudet P; Weiss E
    Plasmid; 1998; 39(1):21-34. PubMed ID: 9473443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gyrase inhibitors can increase gyrA expression and DNA supercoiling.
    Franco RJ; Drlica K
    J Bacteriol; 1989 Dec; 171(12):6573-9. PubMed ID: 2556367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypernegative supercoiling of the DNA template during transcription elongation in vitro.
    Drolet M; Bi X; Liu LF
    J Biol Chem; 1994 Jan; 269(3):2068-74. PubMed ID: 8294458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escherichia coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes.
    DiNardo S; Voelkel KA; Sternglanz R; Reynolds AE; Wright A
    Cell; 1982 Nov; 31(1):43-51. PubMed ID: 6297752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA supercoiling in vivo.
    Giaever GN; Snyder L; Wang JC
    Biophys Chem; 1988 Feb; 29(1-2):7-15. PubMed ID: 2833949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA supercoiling and topoisomerases in Escherichia coli].
    Gómez-Eichelmann MC; Camacho-Carranza R
    Rev Latinoam Microbiol; 1995; 37(3):291-304. PubMed ID: 8850348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli.
    Zechiedrich EL; Khodursky AB; Cozzarelli NR
    Genes Dev; 1997 Oct; 11(19):2580-92. PubMed ID: 9334322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.